- Filed
- Nov 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 7, 2025 | 22.08M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 23.49M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 21.82M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 20.88M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 19.41M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $482K |
| Capex | Q3 2025 · Sep 30, 2024 | $327K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$109.65M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$64.21M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $0 |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $65.04M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $26.06M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $60.65M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $92.85M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$55.65M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$20.22M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $26.42M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $70.71M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $108.27M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | $137.4M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $163.68M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | $67.22M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $44.75M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $22.9M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $128.05M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $109.13M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $28.91M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $131.3M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $72.4M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $179.84M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.03 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$6.59 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$1.55 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$4.64 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.03 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$6.59 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$1.55 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$4.64 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $9.11M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $41.31M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $15M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $44.6M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $38.91M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $104.79M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $20.44M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $52.95M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$47.65M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$143.86M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$49.19M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$47.02M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$32.35M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$90M |
| Net Income restated | Q3 2025 · Jun 30, 2024 | −$30.5M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$27.15M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$48.02M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$146.1M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$34.44M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$96.54M |
| Revenue | Q3 2025 · Sep 30, 2025 | $0 |
| Revenue | Q3 2025 · Sep 30, 2025 | $0 |
| Revenue | Q3 2025 · Sep 30, 2024 | $1M |
| Revenue | Q3 2025 · Sep 30, 2024 | $1M |